The European Commission has finally completed its review of the Cosmetics Regulation as it relates to substances with endocrine-disrupting properties, and for industry at least, the wait was worth it.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?